NEW YORK, NY, Behavidence, a startup company that monitors psychiatric and neurological disorders, announced a $4.3 million seed round led by Welltech Ventures.
Behavidence, a startup company that monitors psychiatric and neurological disorders using artificial intelligence, announced a $4.3 million seed round led by Welltech Ventures, featuring Arc Impact and Longevity Ventures.
Founded in 2020 by Roy Cohen (CEO), Dr. Girish Srinivasan, and Dr. Janine Ellenberger, Behavidence tracks and monitors the mental and emotional state of its users based on their digital usage patterns. Through its unique technology and algorithms, Behavidence can delineate the changes in its users' state of mind without needing identifiable information or monitoring private content or information.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.